HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nuray Aktay Ayaz Selected Research
Nuray Aktay Ayaz Research Topics
Disease
10
Familial Mediterranean Fever (Periodic Disease)
12/2023 - 03/2011
7
Juvenile Arthritis (Juvenile Idiopathic Arthritis)
03/2024 - 05/2020
4
Inflammation (Inflammations)
03/2022 - 03/2011
3
Fever (Fevers)
03/2024 - 03/2022
3
Rheumatic Diseases (Rheumatism)
11/2022 - 05/2020
2
Macrophage Activation Syndrome
03/2024 - 07/2023
2
Diarrhea
05/2023 - 05/2022
2
Arthritis (Polyarthritis)
05/2023 - 12/2020
2
COVID-19
11/2022 - 10/2020
2
Amyloidosis
01/2022 - 01/2021
1
Hepatomegaly
03/2024
1
Splenomegaly
03/2024
1
Whooping Cough (Pertussis)
11/2023
1
Tetanus
11/2023
1
Poliomyelitis (Polio)
11/2023
1
Diphtheria
11/2023
1
Chickenpox
11/2023
1
Myalgia
05/2023
1
Chest Pain (Chest Pains)
05/2023
1
Erysipelas
05/2023
1
Erythema
05/2023
1
Abdominal Pain (Pain, Abdominal)
05/2023
1
Arthralgia (Joint Pain)
05/2023
1
Vomiting
05/2022
1
Aseptic Meningitis
05/2022
1
COVID-19 related pediatric multisystem inflammatory disease
01/2022
1
Injection Site Reaction
01/2022
1
Proteinuria
11/2021
1
Purpura
04/2021
1
Chronic Disease (Chronic Diseases)
03/2021
1
Mevalonate Kinase Deficiency
12/2020
1
Hypersensitivity (Allergy)
05/2020
1
Sacroiliitis
01/2020
1
Low Back Pain (Lumbago)
01/2020
1
Infections
01/2020
1
deficiency of adenosine deaminase 2
01/2020
1
Respiratory Tract Infections (Respiratory Tract Infection)
01/2020
1
Acne Vulgaris
01/2020
1
Connective Tissue Diseases (Connective Tissue Disease)
09/2016
1
Kasabach-Merritt Syndrome
01/2015
1
Thrombocytopenia (Thrombopenia)
01/2015
Drug/Important Bio-Agent (IBA)
11
Colchicine
FDA Link
Generic
12/2023 - 03/2011
4
canakinumab
FDA Link
03/2024 - 09/2021
3
Interleukin 1 Receptor Antagonist Protein (Anakinra)
FDA Link
07/2023 - 03/2011
2
Adalimumab (Humira)
FDA Link
02/2022 - 12/2020
2
Serum Amyloid A Protein (Serum Amyloid A)
IBA
01/2022 - 01/2020
2
Biomarkers (Surrogate Marker)
IBA
04/2021 - 01/2020
1
Interleukins
IBA
03/2024
1
C-Reactive Protein
IBA
03/2024
1
Apoferritins
IBA
03/2024
1
Hepatitis A Vaccines (Hepatitis A Vaccine)
IBA
11/2023
1
Measles-Mumps-Rubella Vaccine (MMR Vaccine)
IBA
11/2023
1
tocilizumab (atlizumab)
FDA Link
07/2023
1
Vaccines
IBA
11/2022
1
mRNA Vaccines
IBA
11/2022
1
BNT162 Vaccine
IBA
11/2022
1
Hemoglobins (Hemoglobin)
IBA
05/2022
1
Acute-Phase Proteins (Acute-Phase Protein)
IBA
03/2022
1
Biosimilar Pharmaceuticals
IBA
02/2022
1
Transaminases (Aminotransferases)
IBA
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
11/2021
1
Methotrexate (Mexate)
FDA Link
Generic
10/2020
1
Leflunomide (Arava)
FDA Link
Generic
10/2020
1
Steroids
IBA
05/2020
1
Isotretinoin (Accutane)
FDA Link
Generic
01/2020
1
Adenosine Deaminase
IBA
01/2020
1
Antibodies
IBA
09/2016
1
Fibrin
IBA
01/2015
1
Interleukin-1 (Interleukin 1)
IBA
03/2011
Therapy/Procedure
3
Therapeutics
03/2024 - 03/2011
3
Transitional Care
01/2024 - 03/2021
1
Duration of Therapy
11/2023
1
Biological Therapy
01/2023
1
Activities of Daily Living (ADL)
02/2022